Beyond effects observed with variants in LRRK2 itself, we found Rab10 phosphorylation was significantly increased in response to pharmacological agents that perturb PD-relevant pathways in iPSC-derived microglia and demonstrated that this was dependent on the kinase activity of LRRK2. The gene discussed is LRRK2; the disease is Parkinson disease.